GO:1902102 | regulation of metaphase/anaphase transition of meiotic cell cycle | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1901993 | regulation of meiotic cell cycle phase transition | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1902103 | negative regulation of metaphase/anaphase transition of meiotic cell cycle | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:0071459 | protein localization to chromosome, centromeric region | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1903083 | protein localization to condensed chromosome | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1905132 | regulation of meiotic chromosome separation | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1905133 | negative regulation of meiotic chromosome separation | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:1901994 | negative regulation of meiotic cell cycle phase transition | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:0044779 | meiotic spindle checkpoint signaling | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:0034501 | protein localization to kinetochore | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:0033316 | meiotic spindle assembly checkpoint signaling | 2.33% (3/129) | 9.86 | 0.0 | 0.0 |
GO:0051447 | negative regulation of meiotic cell cycle | 2.33% (3/129) | 8.91 | 0.0 | 2e-06 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 3.88% (5/129) | 5.7 | 0.0 | 2e-06 |
GO:0033313 | meiotic cell cycle checkpoint signaling | 2.33% (3/129) | 8.64 | 0.0 | 3e-06 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 3.88% (5/129) | 5.44 | 0.0 | 5e-06 |
GO:0034502 | protein localization to chromosome | 2.33% (3/129) | 8.22 | 0.0 | 5e-06 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 3.88% (5/129) | 5.34 | 0.0 | 7e-06 |
GO:2000242 | negative regulation of reproductive process | 2.33% (3/129) | 8.02 | 0.0 | 7e-06 |
GO:0045930 | negative regulation of mitotic cell cycle | 3.88% (5/129) | 5.24 | 0.0 | 8e-06 |
GO:0000075 | cell cycle checkpoint signaling | 3.88% (5/129) | 5.04 | 1e-06 | 1.5e-05 |
GO:1901988 | negative regulation of cell cycle phase transition | 3.88% (5/129) | 4.91 | 1e-06 | 2.2e-05 |
GO:0010948 | negative regulation of cell cycle process | 3.88% (5/129) | 4.91 | 1e-06 | 2.2e-05 |
GO:0007346 | regulation of mitotic cell cycle | 3.88% (5/129) | 4.84 | 1e-06 | 2.6e-05 |
GO:0045786 | negative regulation of cell cycle | 3.88% (5/129) | 4.81 | 1e-06 | 2.7e-05 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 2.33% (3/129) | 7.14 | 1e-06 | 3.3e-05 |
GO:1901987 | regulation of cell cycle phase transition | 3.88% (5/129) | 4.68 | 2e-06 | 4e-05 |
GO:0051445 | regulation of meiotic cell cycle | 2.33% (3/129) | 6.9 | 2e-06 | 5.1e-05 |
GO:0019933 | cAMP-mediated signaling | 1.55% (2/129) | 9.38 | 4e-06 | 7.7e-05 |
GO:0008179 | adenylate cyclase binding | 1.55% (2/129) | 9.38 | 4e-06 | 7.7e-05 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 1.55% (2/129) | 9.38 | 4e-06 | 7.7e-05 |
GO:0035556 | intracellular signal transduction | 5.43% (7/129) | 3.33 | 7e-06 | 0.000131 |
GO:0003676 | nucleic acid binding | 17.83% (23/129) | 1.44 | 1.2e-05 | 0.000143 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 2.33% (3/129) | 6.15 | 1.2e-05 | 0.000143 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:1905819 | negative regulation of chromosome separation | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0051985 | negative regulation of chromosome segregation | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0045839 | negative regulation of mitotic nuclear division | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0033046 | negative regulation of sister chromatid segregation | 2.33% (3/129) | 6.16 | 1.1e-05 | 0.000145 |
GO:0000776 | kinetochore | 2.33% (3/129) | 6.09 | 1.3e-05 | 0.000157 |
GO:0051784 | negative regulation of nuclear division | 2.33% (3/129) | 6.06 | 1.4e-05 | 0.000163 |
GO:0010564 | regulation of cell cycle process | 3.88% (5/129) | 4.18 | 1e-05 | 0.00017 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 2.33% (3/129) | 6.18 | 1.1e-05 | 0.000171 |
GO:0071174 | mitotic spindle checkpoint signaling | 2.33% (3/129) | 6.18 | 1.1e-05 | 0.000171 |
GO:0031577 | spindle checkpoint signaling | 2.33% (3/129) | 6.18 | 1.1e-05 | 0.000171 |
GO:0071173 | spindle assembly checkpoint signaling | 2.33% (3/129) | 6.18 | 1.1e-05 | 0.000171 |
GO:2001251 | negative regulation of chromosome organization | 2.33% (3/129) | 5.85 | 2.2e-05 | 0.00025 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 2.33% (3/129) | 5.76 | 2.6e-05 | 0.000271 |
GO:0010965 | regulation of mitotic sister chromatid separation | 2.33% (3/129) | 5.76 | 2.6e-05 | 0.000271 |
GO:0007088 | regulation of mitotic nuclear division | 2.33% (3/129) | 5.76 | 2.6e-05 | 0.000271 |
GO:1905818 | regulation of chromosome separation | 2.33% (3/129) | 5.76 | 2.6e-05 | 0.000271 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 2.33% (3/129) | 5.76 | 2.6e-05 | 0.000271 |
GO:0007059 | chromosome segregation | 2.33% (3/129) | 5.68 | 3.1e-05 | 0.000315 |
GO:0010639 | negative regulation of organelle organization | 2.33% (3/129) | 5.6 | 3.7e-05 | 0.000367 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 1.55% (2/129) | 7.73 | 4.3e-05 | 0.000421 |
GO:0051129 | negative regulation of cellular component organization | 2.33% (3/129) | 5.47 | 4.7e-05 | 0.000457 |
GO:0004824 | lysine-tRNA ligase activity | 1.55% (2/129) | 7.63 | 4.9e-05 | 0.000457 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.55% (2/129) | 7.63 | 4.9e-05 | 0.000457 |
GO:0051726 | regulation of cell cycle | 3.88% (5/129) | 3.65 | 5.5e-05 | 0.000505 |
GO:0033045 | regulation of sister chromatid segregation | 2.33% (3/129) | 5.38 | 5.7e-05 | 0.000517 |
GO:0051783 | regulation of nuclear division | 2.33% (3/129) | 5.29 | 6.9e-05 | 0.000609 |
GO:0051983 | regulation of chromosome segregation | 2.33% (3/129) | 5.27 | 7.2e-05 | 0.000624 |
GO:0048523 | negative regulation of cellular process | 5.43% (7/129) | 2.78 | 8.2e-05 | 0.000702 |
GO:2000241 | regulation of reproductive process | 2.33% (3/129) | 5.17 | 8.7e-05 | 0.000737 |
GO:0048519 | negative regulation of biological process | 5.43% (7/129) | 2.76 | 9.1e-05 | 0.00076 |
GO:0003729 | mRNA binding | 4.65% (6/129) | 3.05 | 0.0001 | 0.00082 |
GO:0004371 | glycerone kinase activity | 1.55% (2/129) | 7.02 | 0.000116 | 0.000936 |
GO:0044282 | small molecule catabolic process | 3.88% (5/129) | 3.39 | 0.00013 | 0.001037 |
GO:0003723 | RNA binding | 8.53% (11/129) | 1.95 | 0.000145 | 0.00114 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 1.55% (2/129) | 6.83 | 0.00015 | 0.001164 |
GO:0019563 | glycerol catabolic process | 1.55% (2/129) | 6.78 | 0.000161 | 0.001233 |
GO:0019405 | alditol catabolic process | 1.55% (2/129) | 6.76 | 0.000165 | 0.001245 |
GO:1903047 | mitotic cell cycle process | 3.88% (5/129) | 3.23 | 0.000214 | 0.001589 |
GO:0046174 | polyol catabolic process | 1.55% (2/129) | 6.53 | 0.000228 | 0.001672 |
GO:0046164 | alcohol catabolic process | 1.55% (2/129) | 6.46 | 0.000251 | 0.001771 |
GO:0033044 | regulation of chromosome organization | 2.33% (3/129) | 4.67 | 0.000245 | 0.001772 |
GO:0005488 | binding | 36.43% (47/129) | 0.69 | 0.00025 | 0.00179 |
GO:0033314 | mitotic DNA replication checkpoint signaling | 1.55% (2/129) | 6.04 | 0.000449 | 0.003131 |
GO:1901616 | organic hydroxy compound catabolic process | 1.55% (2/129) | 5.98 | 0.000487 | 0.003357 |
GO:0019932 | second-messenger-mediated signaling | 1.55% (2/129) | 5.73 | 0.000687 | 0.004676 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.55% (2/129) | 5.62 | 0.000791 | 0.005194 |
GO:0044818 | mitotic G2/M transition checkpoint | 1.55% (2/129) | 5.62 | 0.000791 | 0.005194 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 1.55% (2/129) | 5.62 | 0.000791 | 0.005194 |
GO:0050794 | regulation of cellular process | 12.4% (16/129) | 1.3 | 0.000814 | 0.00528 |
GO:0019400 | alditol metabolic process | 1.55% (2/129) | 5.56 | 0.000859 | 0.005446 |
GO:0006071 | glycerol metabolic process | 1.55% (2/129) | 5.57 | 0.00085 | 0.005453 |
GO:0099080 | supramolecular complex | 3.1% (4/129) | 3.2 | 0.00103 | 0.006456 |
GO:0097159 | organic cyclic compound binding | 24.81% (32/129) | 0.79 | 0.001178 | 0.007303 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 1.55% (2/129) | 5.25 | 0.00131 | 0.007385 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 1.55% (2/129) | 5.25 | 0.00131 | 0.007385 |
GO:0000076 | DNA replication checkpoint signaling | 1.55% (2/129) | 5.32 | 0.001206 | 0.007398 |
GO:0018105 | peptidyl-serine phosphorylation | 2.33% (3/129) | 3.83 | 0.001308 | 0.007526 |
GO:0018209 | peptidyl-serine modification | 2.33% (3/129) | 3.83 | 0.001308 | 0.007526 |
GO:0043066 | negative regulation of apoptotic process | 0.78% (1/129) | 9.6 | 0.001287 | 0.007561 |
GO:0043228 | non-membrane-bounded organelle | 5.43% (7/129) | 2.12 | 0.001261 | 0.007564 |
GO:0050789 | regulation of biological process | 12.4% (16/129) | 1.23 | 0.001358 | 0.007577 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 1.55% (2/129) | 5.27 | 0.001279 | 0.00759 |
GO:0043232 | intracellular non-membrane-bounded organelle | 5.43% (7/129) | 2.12 | 0.00126 | 0.00764 |
GO:0033365 | protein localization to organelle | 3.1% (4/129) | 3.0 | 0.001679 | 0.009277 |
GO:0043226 | organelle | 16.28% (21/129) | 1.0 | 0.001792 | 0.009707 |
GO:0043229 | intracellular organelle | 16.28% (21/129) | 1.0 | 0.00179 | 0.00979 |
GO:0033043 | regulation of organelle organization | 2.33% (3/129) | 3.61 | 0.002027 | 0.010771 |
GO:0043484 | regulation of RNA splicing | 1.55% (2/129) | 4.94 | 0.002018 | 0.010829 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 1.55% (2/129) | 4.84 | 0.002314 | 0.01207 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.1% (4/129) | 2.88 | 0.002296 | 0.012087 |
GO:1903046 | meiotic cell cycle process | 2.33% (3/129) | 3.5 | 0.002519 | 0.013014 |
GO:0007165 | signal transduction | 5.43% (7/129) | 1.92 | 0.002676 | 0.013697 |
GO:0065007 | biological regulation | 12.4% (16/129) | 1.13 | 0.002769 | 0.014044 |
GO:0022402 | cell cycle process | 3.88% (5/129) | 2.39 | 0.002863 | 0.014392 |
GO:0005634 | nucleus | 9.3% (12/129) | 1.33 | 0.003117 | 0.015123 |
GO:0000049 | tRNA binding | 1.55% (2/129) | 4.62 | 0.00309 | 0.015127 |
GO:0042770 | signal transduction in response to DNA damage | 1.55% (2/129) | 4.63 | 0.003074 | 0.015182 |
GO:0000077 | DNA damage checkpoint signaling | 1.55% (2/129) | 4.63 | 0.003074 | 0.015182 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3.1% (4/129) | 2.74 | 0.003194 | 0.015365 |
GO:1901360 | organic cyclic compound metabolic process | 11.63% (15/129) | 1.13 | 0.003582 | 0.017084 |
GO:0006270 | DNA replication initiation | 1.55% (2/129) | 4.5 | 0.003655 | 0.017282 |
GO:0051128 | regulation of cellular component organization | 2.33% (3/129) | 3.29 | 0.003731 | 0.017497 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.63% (15/129) | 1.12 | 0.003859 | 0.017795 |
GO:0044281 | small molecule metabolic process | 6.98% (9/129) | 1.55 | 0.003839 | 0.017853 |
GO:0046983 | protein dimerization activity | 3.1% (4/129) | 2.66 | 0.003948 | 0.018057 |
GO:0008270 | zinc ion binding | 4.65% (6/129) | 2.01 | 0.003985 | 0.018078 |
GO:0043231 | intracellular membrane-bounded organelle | 13.95% (18/129) | 0.99 | 0.004024 | 0.018106 |
GO:0006635 | fatty acid beta-oxidation | 1.55% (2/129) | 4.39 | 0.004208 | 0.018784 |
GO:0043227 | membrane-bounded organelle | 13.95% (18/129) | 0.98 | 0.004349 | 0.01926 |
GO:0042981 | regulation of apoptotic process | 0.78% (1/129) | 7.79 | 0.004498 | 0.01961 |
GO:0019395 | fatty acid oxidation | 1.55% (2/129) | 4.35 | 0.004489 | 0.019721 |
GO:0044238 | primary metabolic process | 23.26% (30/129) | 0.69 | 0.004788 | 0.020712 |
GO:0031570 | DNA integrity checkpoint signaling | 1.55% (2/129) | 4.27 | 0.004975 | 0.021354 |
GO:0016054 | organic acid catabolic process | 2.33% (3/129) | 3.12 | 0.005185 | 0.021918 |
GO:0046395 | carboxylic acid catabolic process | 2.33% (3/129) | 3.12 | 0.005185 | 0.021918 |
GO:0009062 | fatty acid catabolic process | 1.55% (2/129) | 4.17 | 0.005674 | 0.023627 |
GO:0046483 | heterocycle metabolic process | 10.85% (14/129) | 1.11 | 0.005643 | 0.023677 |
GO:0090304 | nucleic acid metabolic process | 9.3% (12/129) | 1.22 | 0.005739 | 0.023723 |
GO:0071013 | catalytic step 2 spliceosome | 1.55% (2/129) | 4.14 | 0.005909 | 0.024244 |
GO:0043069 | negative regulation of programmed cell death | 0.78% (1/129) | 7.38 | 0.005993 | 0.024411 |
GO:0006725 | cellular aromatic compound metabolic process | 10.85% (14/129) | 1.08 | 0.006857 | 0.027726 |
GO:1901575 | organic substance catabolic process | 5.43% (7/129) | 1.65 | 0.007314 | 0.029361 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.08% (13/129) | 1.1 | 0.007911 | 0.031529 |
GO:0019751 | polyol metabolic process | 1.55% (2/129) | 3.9 | 0.008146 | 0.032236 |
GO:0009055 | electron transfer activity | 1.55% (2/129) | 3.89 | 0.008296 | 0.032601 |
GO:0072329 | monocarboxylic acid catabolic process | 1.55% (2/129) | 3.88 | 0.008372 | 0.032668 |
GO:0016052 | carbohydrate catabolic process | 2.33% (3/129) | 2.83 | 0.009025 | 0.034025 |
GO:0022625 | cytosolic large ribosomal subunit | 1.55% (2/129) | 3.84 | 0.008781 | 0.034028 |
GO:0004372 | glycine hydroxymethyltransferase activity | 0.78% (1/129) | 6.79 | 0.008977 | 0.034075 |
GO:0019264 | glycine biosynthetic process from serine | 0.78% (1/129) | 6.79 | 0.008977 | 0.034075 |
GO:0070905 | serine binding | 0.78% (1/129) | 6.79 | 0.008977 | 0.034075 |
GO:0022414 | reproductive process | 2.33% (3/129) | 2.81 | 0.009362 | 0.034827 |
GO:0009056 | catabolic process | 5.43% (7/129) | 1.58 | 0.009457 | 0.034947 |
GO:0006006 | glucose metabolic process | 1.55% (2/129) | 3.8 | 0.009358 | 0.035047 |
GO:0003674 | molecular_function | 45.74% (59/129) | 0.37 | 0.009619 | 0.035311 |
GO:0034440 | lipid oxidation | 1.55% (2/129) | 3.77 | 0.009734 | 0.035502 |
GO:0004347 | glucose-6-phosphate isomerase activity | 0.78% (1/129) | 6.6 | 0.010253 | 0.037149 |
GO:0005829 | cytosol | 4.65% (6/129) | 1.71 | 0.010564 | 0.038029 |
GO:0006565 | L-serine catabolic process | 0.78% (1/129) | 6.54 | 0.010677 | 0.038193 |
GO:0044248 | cellular catabolic process | 3.88% (5/129) | 1.92 | 0.010783 | 0.038325 |
GO:0071704 | organic substance metabolic process | 23.26% (30/129) | 0.61 | 0.011166 | 0.039433 |
GO:0019752 | carboxylic acid metabolic process | 4.65% (6/129) | 1.68 | 0.011866 | 0.041644 |
GO:0006082 | organic acid metabolic process | 4.65% (6/129) | 1.67 | 0.012063 | 0.041809 |
GO:0043436 | oxoacid metabolic process | 4.65% (6/129) | 1.67 | 0.01202 | 0.041919 |
GO:0046655 | folic acid metabolic process | 0.78% (1/129) | 6.33 | 0.012375 | 0.042626 |
GO:0015934 | large ribosomal subunit | 1.55% (2/129) | 3.56 | 0.012793 | 0.043526 |
GO:1901615 | organic hydroxy compound metabolic process | 2.33% (3/129) | 2.64 | 0.012748 | 0.043642 |
GO:0003838 | sterol 24-C-methyltransferase activity | 0.78% (1/129) | 6.25 | 0.013011 | 0.044002 |
GO:0016070 | RNA metabolic process | 6.2% (8/129) | 1.35 | 0.013775 | 0.046304 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 0.78% (1/129) | 6.1 | 0.014494 | 0.04814 |
GO:0003677 | DNA binding | 6.98% (9/129) | 1.24 | 0.014489 | 0.048413 |
GO:0051252 | regulation of RNA metabolic process | 6.2% (8/129) | 1.34 | 0.014681 | 0.048473 |